Opendata, web and dolomites

LIGHT4LUNGS SIGNED

Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LIGHT4LUNGS project word cloud

Explore the words cloud of the LIGHT4LUNGS project. It provides you a very rough idea of what is the project "LIGHT4LUNGS" about.

light    antimicrobial    organs    bacterial    encompasses    excite    multidrug    treatment    persistent    action    local    oxygen    fibrosis    photonics    eliminated    invasive    cytotoxic    porphyrins    avoiding    nanotechnology    iron    physical    whereby    luminescence    hospital    therapeutic    endogenous    lung    effect    species    tissue    source    elicit    clinically    free    patients    photosensitisers    replaced    morbidity    advantage    reactive    extended    paradigms    itself    light4lungs    recalcitrant    inhalable    toxicity    host    lungs    models    added    departs    photosensitiser    scientific    irrespective    tract    expertise    sources    materials    definition    pathogenic    photosensitising    acquired    medicine    eliminating    science    efficacy    antibiotics    lightning    mortality    resistance    tethers    lack    tests    diseases    combines    cystic    healthcare    combined    profile    activation    breathable    chronic    nanomedicine    photodynamic    drug    self    internal    particles    scheme    infections    externally    respiratory    aerosol    safe    bacteria   

Project "LIGHT4LUNGS" data sheet

The following table provides information about the project.

Coordinator
INSTITUT QUIMIC DE SARRIA 

Organization address
address: CALLE VIA AUGUSTA 384-394
city: Barcelona
postcode: 8017
website: www.iqs.edu

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙493˙625 €
 EC max contribution 3˙493˙625 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2023-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT QUIMIC DE SARRIA ES (Barcelona) coordinator 714˙375.00
2    UNIVERSITA DEGLI STUDI DI FIRENZE IT (Florence) participant 593˙125.00
3    THE UNIVERSITY OF LIVERPOOL UK (LIVERPOOL) participant 532˙500.00
4    UNIVERSITA DEGLI STUDI DI PADOVA IT (PADOVA) participant 410˙000.00
5    FUNDACIO PRIVADA INSTITUT CATALA D'INVESTIGACIO QUIMICA ES (TARRAGONA) participant 372˙500.00
6    CARDIFF SCINTIGRAPHICS LIMITED UK (CARDIFF) participant 336˙875.00
7    SORBONNE UNIVERSITE FR (PARIS) participant 294˙250.00
8    WEDO PROJECT INTELLIGENCE MADE EASY SL ES (BARCELONA) participant 240˙000.00

Map

 Project objective

Light4lungs addresses the problem of antimicrobial resistance in the treatment of chronic lung infections, which are the leading cause of morbidity and mortality in patients with diseases such as cystic fibrosis and hospital-acquired lung infections. The goal is to develop a novel therapeutic scheme for the treatment of the infections, whereby antibiotics will be replaced by inhalable light sources that will excite bacterial endogenous photosensitisers (e.g., iron-free porphyrins), eliminating the pathogenic bacteria by the photodynamic effect (local production of cytotoxic reactive oxygen species by the combined action of light, a photosensitiser and oxygen) irrespective of its multidrug resistance profile. The treatment will be safe for the host tissue because of its lack of self-photosensitising ability. Light4Lungs departs from current paradigms: (1) bacterial infections will be treated without antibiotics, which will be replaced by breathable light sources; (2) bacteria will be eliminated without any externally-added drug, taking advantage of endogenous photosensitisers; (3) a breathable light source will be used to elicit the therapeutic action, avoiding the use of invasive physical tethers to deliver light to the lungs. The project encompasses the development of particles with persistent luminescence, the aerosol technology for activation and delivery to the lungs, and the definition of the treatment parameters through toxicity and efficacy tests in clinically relevant models of respiratory infections. The project combines several different scientific expertise from photonics to medicine. The results will be useful for patients with recalcitrant respiratory tract bacterial infections and will eventually be extended to other diseases in the lungs and in other internal organs. The impact reaches beyond antimicrobial resistance itself and will affect many other fields such as healthcare, nanomedicine, materials science and nanotechnology and lightning

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIGHT4LUNGS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIGHT4LUNGS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

BRIEFING (2018)

Bridging the FET Innovation Gap

Read More  

SHERO (2019)

Self-HEaling soft RObotics

Read More